The recent demonstration of the dramatic therapeutic effectiveness of the adrenal 11, 17-oxysteroids (Compound E of Kendall) in the therapy of rheumatoid arthritis, rheumatic fever, and lupus erythematosus has lent great impetus to the study of the role of the adrenal cortex in these mesenchymal diseases, and to the search for new methods of stimulating the adrenal to produce endogenously these therapeutic agents in greater abundance (1) (2) (3) . The wide variety of stimuli capable of producing an "alarm reaction" are all attended by one common factor, the stimulation of the autonomic nervous system with the consequent release of epinephrine (4) . That epinephrine is capable of increasing pituitary secretion of adrenocorticotrophic hormone (ACTH), which, in the presence of normal adrenals, results in augmented adrenal cortical activity has been demonstrated in animals (4) and in man (3) .
Following the administration of ACTH to patients with normal adrenal glands a characteristic pattern of hematological changes occurs (5, 6) . These alterations include a decrease in circulating lymphocytes and eosinophils, the latter more pronounced than the former, and appear to be the result of an increased secretion of 11, 17-oxysteroids by the adrenal cortex (5, 6) . The eosinopenic effect of epinephrine, dependent on the integrity of the anterior pituitary and adrenal cortex, has been utilized by Thorn and adrenal cortical steroid hormone production with resultant eosinopenia and increased urinary 11-oxysteroid and 17-ketosteroid excretion.
Although long suspected, it has only recently been proven that the adrenal medulla secretes two hormones, epinephrine and its non-methylated analogue, nor-epinephrine (arterenol, 1-[3, 4-dehydroxyphenyl] 2-aminoethanol) (7, 8) . Assays on U. S. P. epinephrine reference standards, and U. S. P. commercial epinephrine revealed a nor-epinephrine content varying from 10 to 35%, the average being 15%o (7-9). The present study was undertaken to determine which of the medullary hormones in U. S. P. commercial epinephrine is responsible for the eosinopenia secondary to anterior pituitary-adrenal cortical stimulation. The percentage drop in total circulating eosinophils is the most sensitive hematological measure of increased 11, 17-oxysteroid secretion by the cortical cells (5, 6, 10) , and was therefore utilized as the criterion in this study.
METHOD
Fifteen normal male subjects were used. After a 12 hour fast a basal eosinophil count was done and the subject given, on different days, 0.3 cc. of 1:1,000 (300 iAg.) U. S. P. epinephrine, nor-epinephrine (Winthrop), synthetic L-epinephrine (Winthrop), and saline as a control. Four hours later a repeat count was made. This period of time was chosen because maximum eosinopenic effect occurs then (5, 10) . Food was withheld for the four hours since it has been shown that an ordinary meal may decrease the eosinophil count (11) .
Total circulating eosinophil counts were done on freshly drawn oxalated blood by the chamber technic (10, 12, 13) . Heparin was not used because it is known to cause, in vitro, dissolution and agglutination of leukocytes within one hour (14, 15) . Two standard white blood cell pipettes were used for each count. These same pipettes were again used for the repeat count, four hours later, in order to reduce the error of the method. The 789 pipettes were filled to the 0.5 mark and diluted to the 11 mark with a special diluent (0.1 Gm. Phloxin B, 100 cc. propylene glycol, 100 cc. distilled water) (12, 16 This indicates that the anterior pituitary-adrenal cortical stimulating effect of U. S. P. epinephrine, measured by its eosinopenic action, is attendant on its L-epinephrine content and not on the nor-epinephrine which is present.
COMMENTS
The pharmacological differences between the naturally occurring hormones of the adrenal medulla, epinephrine and nor-epinephrine, have been stressed by several investigators (7, (17) (18) (19) . The former, within physiological range, is an overall vasodilator, the increase in blood pressure being secondary to increased cardiac output. Nor-epinephrine is an overall vasoconstrictor with little, if any, effect on cardiac output. As far as their ability to stimulate the anterior pituitary-adrenal cortical mechanism, measured by the decrease in total circulating eosinophils, these hormones are again strikingly dissimilar. Epinephrine acts as a potent eosinopenic agent, whereas nor-epinephrine is devoid of any significant effect. This is in agreement with Thorn's statement which was published subsequent to the inception of this study (3) .
The exact role that the hypothalamus plays in the anterior pituitary-adrenal cortical response to stress has not been fully elucidated. Recently, it has been demonstrated in rats that the hypothalamo-hypophyseal neural and vascular connections are not necessary for the stimulation of the anterior pituitary-adrenal cortical axis in response to stress (20, 21 lation which follows stress, and that extracts of hypothalamic tissue are capable of stimulating ACTH production in animals rendered unresponsive by these lesions. This suggests that anterior hypothalamic centers secrete a neurohumor following stress and epinephrine administration which increases production of ACTH resulting in augmented output of 11, 17-oxysteroids by the adrenal cortex (3).
SUMMARY AND CONCLUSIONS
The eosinopenic effects of U. S. P. epinephrine, synthetic L-epinephrine, and nor-epinephrine were compared in 15 normal subjects. Another pharmacological difference between the adrenal medullary hormones has been demonstrated. The eosinopenic effect of U. S. P. epinephrine depends on its L-epinephrine content and not on the norepinephrine present. Epinephrine is the anterior pituitary-adrenal cortical stimulant, whereas its non-methylated analogue, nor-epinephrine, is devoid of effect.
